People Background Check
Find People:

Yan L Yang, Age 605209 92Nd St, Elmhurst, NY 11373

Get Report
Known as:
Yanling Yang
Related to:
Nyung Sook Han 90 Paul Yang 53

Yan Yang Phones & Addresses

Elmhurst, NY

Seattle, WA

Mentions for Yan L Yang

Career records & work history

Lawyers & Attorneys

Yan Yang Photo 1

Yan Yang - Lawyer

Address:
New Horizon Capital
(108) 950-8426 (Office)
Licenses:
New York - Currently registered 1996
Education:
Columbia University School of Law
Yan Yang Photo 2

Yan Rong Yang

Medicine Doctors

Yan Yang

Specialties:
Physical Medicine & Rehabilitation, Acupuncturist
Work:
East Pao Corporation
2801 Rodeo Rd STE F, Santa Fe, NM 87507
(505) 438-7178 (phone) (505) 438-1056 (fax)
Education:
Medical School
Chongqing Med Univ, Chongqing City, Sichuan, China
Graduated: 1982
Languages:
Chinese, English, French, German, Spanish
Description:
Dr. Yang graduated from the Chongqing Med Univ, Chongqing City, Sichuan, China in 1982. She works in Santa Fe, NM and specializes in Physical Medicine & Rehabilitation and Acupuncturist.

Yan Yang

Specialties:
Nephrology
Work:
Dialysis Associates
950 W Magnolia Ave, Fort Worth, TX 76104
(817) 336-5060 (phone) (817) 336-1744 (fax)
Southwest Dialysis Center
4804 Bryant Irvin Ct, Fort Worth, TX 76107
(817) 738-8703 (phone) (817) 732-6126 (fax)
Conditions:
Acute Renal Failure, Chronic Renal Disease, Diabetes Mellitus (DM), Heart Failure, Septicemia, Calculus of the Urinary System, Cardiac Arrhythmia, Hypertension (HTN), Poisoning by Drugs, Meds, or Biological Substances, Systemic Lupus Erythematosus
Languages:
English
Description:
Dr. Yang works in Fort Worth, TX and 1 other location and specializes in Nephrology. Dr. Yang is affiliated with Baylor Scott & White Medical Center Waxahachie, Texas Health Harris Methodist Hospital Fort Worth, Texas Health Harris Methodist Hospital Southwest Fort Worth and Texas Health Huguley Fort Worth South.

Yan Jin Yang

Specialties:
Internal Medicine
Work:
Park Slope Medicine
1230 Ave U FL 1, Brooklyn, NY 11229
(718) 787-9067 (phone) (718) 382-3972 (fax)
Languages:
Chinese, English
Description:
Dr. Yang works in Brooklyn, NY and specializes in Internal Medicine. Dr. Yang is affiliated with New York Methodist Hospital.

License Records

Yan Yang

Address:
14133 78 Ave APT 3B, Flushing, NY 11367
Licenses:
License #: FV9566058 - Active
Category: Cosmetology
Issued Date: Apr 22, 2009
Effective Date: Apr 22, 2009
Expiration Date: Oct 31, 2018
Type: Nail Specialist

Yan Yang resumes & CV records

Resumes

Yan Yang Photo 48

Yan Yang - Elmhurst, NY

Work:
LANZHOU JIAOTONG UNIVERSITY 2013 to 2013
Staff Accountant AGRICULTURAL BANK OF CHINA - Lanzhou, CN 2011 to 2011
Customer Service Associate LANZHOU RAILWAYS BUREAU - Lanzhou, CN 2010 to 2010
Staff Accountant
Education:
FORDHAM UNIVERSITY, GRADUATE SCHOOL OF BUSINESS ADMINISTRATION - New York, NY 2012 to 2014
MS in Accounting ZHONGNAN UNIVERSITY OF ECOMONICS AND LAW - Wuhan, CN 2008 to 2012
Bachelor of Management in Accounting
Skills:
Quickbooks, Excel

Publications & IP owners

Wikipedia

Yan Yang Photo 54

Yang Yan

Yang Yan (simplified Chinese: ??; traditional Chinese: ??; pinyin: Yng Yn; Wade-Giles: Yang 2 Yen 2) (727-781), courtesy name Gongnan (??), was an official ...
Yan Yang Photo 55

Empress Yang Yan

Empress Yang Yan (??) (238-274), courtesy name Qiongzhi (??), formally Empress Wuyuan was an empress of Jin Dynasty (265-420). She was the first wife of Emperor Wu.

Us Patents

Immediate Release Formulations Of 1-Aminocyclohexane Compounds, Memantine And Neramexane

US Patent:
2006000, Jan 5, 2006
Filed:
Jun 16, 2005
Appl. No.:
11/155319
Inventors:
Yan Yang - Roslyn Heights NY, US
Rajiv Janjikhel - South Setauket NY, US
Niranjan Rao - Belle Mead NY, US
Antonia Periclou - Jersey City NJ, US
Wattanaporn Abramowitz - Hillsborough NJ, US
Mahendra Dedhiya - Pomona NY, US
Erhard Seiller - Nidderau, DE
Bernhard Hauptmeier - Gelnhausen, DE
Assignee:
Forest Laboratories, Inc. - New York NY
International Classification:
A61K 9/20
A61K 31/13
US Classification:
424464000, 514662000
Abstract:
The present invention relates to an immediate release solid oral dosage form containing 1-aminocyclohexanes, preferably memantine or neramexane, and optionally a pharmaceutically acceptable coating, wherein the active ingredient exhibits dose proportionality and is released at a dissolution rate of more than about 80% within about the first 60 minutes following entry of said form into a use environment. The dosage form is direct compressed and has a hardness within the range of between about 3 and about 40 Kp, exhibits an average Twithin the range of about 2 to about 8 hours with an active ingredient load within the range of about 2.5 to about 150 mg. The formulation allows for dose-proportional compositions for once daily or b.i.d. dosing, while maintaining a steady average range of T.

Immediate Release Formulations Of 1-Aminocyclohexane Compounds, Memantine And Neramexane

US Patent:
2006019, Sep 7, 2006
Filed:
Dec 14, 2005
Appl. No.:
11/304976
Inventors:
Yan Yang - Roslyn Heights NY, US
Rajiv Janjikhel - Bridgewater NY, US
Niranjan Rao - Belle Mead NJ, US
Antonia Periclou - Jersey City NJ, US
Wattanaporn Abramowitz - West Windsor NJ, US
Mahendra Dedhiya - Pomona NY, US
Erhard Seiller - Nidderau, DE
Bernhard Hauptmeier - Gelnhausen, DE
Assignee:
Forest Laboratories, Inc. - New York NY
International Classification:
A61K 31/13
A61K 9/20
US Classification:
424464000, 514663000
Abstract:
The present invention relates to an immediate release solid oral dosage form containing 1-aminocyclohexanes, preferably memantine or neramexane, and optionally a pharmaceutically acceptable coating, wherein the active ingredient exhibits dose proportionality and is released at a dissolution rate of more than about 80% within about the first 60 minutes following entry of said form into a use environment. The dosage form is direct compressed and has a hardness within the range of between about 3 and about 40 Kp, exhibits an average Twithin the range of about 2 to about 8 hours with an active ingredient load within the range of about 2.5 to about 150 mg. The formulation allows for dose-proportional compositions for once daily or b.i.d. dosing, while maintaining a steady average range of T.

Modified And Pulsatile Release Pharmaceutical Formulations Of Escitalopram

US Patent:
2007013, Jun 14, 2007
Filed:
Dec 13, 2006
Appl. No.:
11/610194
Inventors:
Mahendra Dedhiya - Pomona NY, US
Anil Chhettry - Holtsville NY, US
Yan Yang - Roslyn Heights NY, US
Assignee:
Forest Laboratories, Inc. - New York NY
International Classification:
A61K 9/20
A61K 31/343
US Classification:
424464000, 514469000
Abstract:
The present invention relates to modified and pulsatile release pharmaceutical formulations of escitalopram and their use for the treatment of central nervous system disorders, including mood disorders (e.g., major depressive disorder) and anxiety disorders (e.g., generalized anxiety disorder, social anxiety disorder, post traumatic stress disorder, and panic disorder, including panic attacks).

Compositions Comprising Cyclohexylamines And Aminoadamantanes

US Patent:
2007027, Nov 22, 2007
Filed:
Nov 5, 2004
Appl. No.:
10/578765
Inventors:
Mahendra Dedhiya - Pomona NY, US
Shashank Mahashabde - Kendell Park NJ, US
Yan Yang - Roslyn Heights NY, US
Anshu Goel - Levittown NY, US
Erhard Seiller - Nidderau, DE
Bernhard Hauptmeier - Gelnhausen, DE
International Classification:
A61K 31/136
A61K 31/13
A61P 25/00
US Classification:
514662000, 514579000
Abstract:
The invention is directed to formulations of pharmaceutical compounds, such as the Cyclohexylamines and Aminoadamantanes which have antimicrobial properties. In particular, it is directed to aqueous based formulations with reduced amounts of preservatives which allow safe and convenient administration and flexible dosing and which, in the case of oral formulations, are easy to swallow. Optionally, the compositions contain components that provide the requisite stability and shelf life while reducing or avoiding incrustation of the composition around the container closure which leads to leaks and difficulty in opening the container.

Immediate Release Formulations Of 1-Aminocyclohexane Compounds, Memantine And Neramexane

US Patent:
2010002, Feb 4, 2010
Filed:
Mar 24, 2009
Appl. No.:
12/410224
Inventors:
Yan Yang - Roslyn Heights NY, US
Rajiv Janjikhel - South Setauket NY, US
Niranjan Rao - Belle Mead NJ, US
Antonia Periclou - Jersey City NJ, US
Wattanaporn Abramowitz - West Windsor NJ, US
Mahendra G. Dedhiya - Pomona NY, US
Erhard Seiller - Nidderau, DE
Bernhard Hauptmeier - Gelnhausen, DE
Assignee:
Forest Laboratories, Inc. - New York NY
International Classification:
A61K 9/22
A61K 31/13
US Classification:
424468, 514662
Abstract:
The present invention relates to an immediate release solid oral dosage form containing 1-aminocyclohexanes, preferably memantine or neramexane, and optionally a pharmaceutically acceptable coating, wherein the active ingredient exhibits dose proportionality and is released at a dissolution rate of more than about 80% within about the first 60 minutes following entry of said form into a use environment. The dosage form is direct compressed and has a hardness within the range of between about 3 and about 40 Kp, exhibits an average Twithin the range of about 2 to about 8 hours with an active ingredient load within the range of about 2.5 to about 150 mg. The formulation allows for dose-proportional compositions for once daily or b.i.d. dosing, while maintaining a steady average range of T.

Compositions Comprising Cyclohexylamines And Aminoadamantanes

US Patent:
2010003, Feb 11, 2010
Filed:
Oct 14, 2009
Appl. No.:
12/587885
Inventors:
Mahendra G. Dedhiya - Pomona NY, US
Shashank Mahashabde - Kendell Park NJ, US
Yan Yang - Roslyn Heights NY, US
Anshu Goel - Levittown NY, US
Erhard Seiller - Nidderau, DE
Bernhard Hauptmeier - Gelnhausen, DE
Assignee:
MERZ PHARMA GMBH & CO. KGAA - FRANKFURT AM MAIN
International Classification:
A61K 31/13
US Classification:
514579
Abstract:
The invention is directed to formulations of pharmaceutical compounds, such as the Cyclohexylamines and Aminoadamantanes which have antimicrobial properties. In particular, it is directed to aqueous based formulations with reduced amounts of preservatives which allow safe and convenient administration and flexible dosing and which, in the case of oral formulations, are easy to swallow. Optionally, the compositions contain components that provide the requisite stability and shelf life while reducing or avoiding incrustation of the composition around the container closure which leads to leaks and difficulty in opening the container.

Milnacipran Formulations

US Patent:
2010028, Nov 11, 2010
Filed:
May 5, 2010
Appl. No.:
12/774446
Inventors:
Mahendra G. Dedhiya - Pomona NY, US
Anil Chhettry - Holtsville NY, US
Yan Yang - Roslyn Heights NY, US
Yun Mo - Commack NY, US
Bhaveshkumar H. Kothari - Smithtown NY, US
Assignee:
Forest Laboratories Holdings Ltd. - Hamilton
International Classification:
A61K 31/365
A61P 1/08
A61P 25/22
A61P 13/00
A61P 1/12
US Classification:
514470
Abstract:
The present invention provides formulations comprising milnacipran or pharmaceutically acceptable salts thereof (e.g., milnacipran hydrochloride), including immediate release formulations and modified formulations, such as delayed release and extended release formulations. The present invention provides formulations with improved stability and high bioavailability. Processes for preparing the formulations as well as methods of treating conditions by administering the formulations are also described.

Immediate Release Formulations Of 1-Aminocyclohexane Compounds, Memantine And Neramexane

US Patent:
2011023, Sep 29, 2011
Filed:
Jun 8, 2011
Appl. No.:
13/134467
Inventors:
Yan Yang - Roslyn Heights NY, US
Rajiv Janjikhel - South Setauket NY, US
Niranjan Rao - Belle Mead NJ, US
Antonia Periclou - Jersey City NJ, US
Wattanaporn Abramowitz - Hillsborough NJ, US
Mahendra G. Dedhiya - Pomona NY, US
Erhard Seiller - Nidderau, DE
Bernhard Hauptmeier - Gelnhausen, DE
Assignee:
FOREST LABORATORIES HOLDINGS LIMITED - Hamilton
International Classification:
A61K 9/00
A61K 31/13
A61K 31/205
A61P 25/28
A61P 25/16
A61P 25/04
A61P 25/08
A61P 27/06
A61P 25/24
A61P 31/14
A61P 33/06
A61P 1/16
A61P 25/00
US Classification:
424400, 514579, 514554
Abstract:
The present invention relates to an immediate release solid oral dosage form containing 1-aminocyclohexanes, preferably memantine or neramexane, and optionally a pharmaceutically acceptable coating, wherein the active ingredient exhibits dose proportionality and is released at a dissolution rate of more than about 80% within about the first 60 minutes following entry of said form into a use environment. The dosage form is direct compressed and has a hardness within the range of between about 3 and about 40 Kp, exhibits an average Twithin the range of about 2 to about 8 hours with an active ingredient load within the range of about 2.5 to about 150 mg. The formulation allows for dose-proportional compositions for once daily or b.i.d. dosing, while maintaining a steady average range of T.

Amazon

Yan Yang Photo 56

Yang Yan Lotus Paintings (Fine) China Ink Artists Series(Chinese Edition)

Author:
XU HONG QUAN
Publisher:
Jiangxi Fine Arts Pub. Date :2010-10-01 version 1
Binding:
Paperback
ISBN #:
7548003641
EAN Code:
9787548003649

Possible Relatives

David Yang  A Yang  Deborah L Yang  Daniel P Yang  Dee T Yang  Denise K Yang  Danny W Yang  Yan G Lee  Yan G Li  Yan C Lin 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.